U.S. Physical Therapy stock gains on Q2 2026 revenue and margin growth

Published on 09/19/2026 at 10:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

U.S. Physical Therapy stock is supported by Q2 2026 revenue of USD 214 million, up 8.5 percent year over year as of the quarter ended June 30, 2026. The company also expanded its clinic operating margin and raised full-year guidance for 2026.

USPH, US9175021020, Illustration mit AI erstellt.

U.S. Physical Therapy stock (ISIN US9175021020) is backed by solid operating momentum, with the company reporting second-quarter 2026 revenue of USD 214 million, an 8.5 percent increase year over year for the period ended June 30, 2026, driven by higher patient volumes and improved net rates per visit, according to Scanx Trade.

Q2 2026 earnings underpin U.S. Physical Therapy stock

As of the second quarter of 2026, U.S. Physical Therapy reported that clinic revenue reached USD 214 million, up from about USD 197 million a year earlier, reflecting an 8.5 percent year-over-year increase that underscores steady demand for outpatient physical therapy services, according to Scanx Trade.

According to the same Q2 2026 overview, the company improved its clinic operating margin for the quarter, benefiting from operational efficiencies and strong net rates per visit, which helped earnings grow faster than revenue, as reported by Scanx Trade.

Guidance and growth outlook for 2026

Per the Q2 2026 update, management reiterated and modestly raised its guidance for full-year 2026 clinic revenue, signaling confidence that volume growth and favorable pricing can sustain a high single-digit expansion rate compared with 2025, according to Scanx Trade.

For investors, the combination of revenue up 8.5 percent year over year in Q2 2026 and expanding operating margins suggests that the company is currently managing labor and facility costs effectively while still growing its clinic footprint, according to Scanx Trade.

Stock level and investor takeaway

As of September 18, 2026, U.S. Physical Therapy stock on the New York Stock Exchange traded in a range consistent with its recent performance, with the Q2 2026 figures providing fundamental support for the shares even as broader U.S. equity markets showed a mixed picture at the close described by Emirates News Agency.